APA (7th ed.) Citation

Trova, S., Al-Amere, M., Mistry, J. J., Eraslan, Z., Alhazmi, B., Harris-Folb, J., . . . Khanim, F. L. (2019). Diffuse Large B Cell Lymphoma (DLBCL)-Released NM23-H1 Promotes Monocyte Survival and Inflammatory Cytokine Release: A Mechanistic Link between the Dual Impacts of NM23-H1 Expression and Reduced Lymphocyte:Monocyte Ratio in DLBCL Prognosis. Blood, 134(Supplement_1), 2803. https://doi.org/10.1182/blood-2019-130889

Chicago Style (17th ed.) Citation

Trova, Sandro, et al. "Diffuse Large B Cell Lymphoma (DLBCL)-Released NM23-H1 Promotes Monocyte Survival and Inflammatory Cytokine Release: A Mechanistic Link Between the Dual Impacts of NM23-H1 Expression and Reduced Lymphocyte:Monocyte Ratio in DLBCL Prognosis." Blood 134, no. Supplement_1 (2019): 2803. https://doi.org/10.1182/blood-2019-130889.

MLA (9th ed.) Citation

Trova, Sandro, et al. "Diffuse Large B Cell Lymphoma (DLBCL)-Released NM23-H1 Promotes Monocyte Survival and Inflammatory Cytokine Release: A Mechanistic Link Between the Dual Impacts of NM23-H1 Expression and Reduced Lymphocyte:Monocyte Ratio in DLBCL Prognosis." Blood, vol. 134, no. Supplement_1, 2019, p. 2803, https://doi.org/10.1182/blood-2019-130889.